Solventum jumps after Q1 EPS beat, reaffirms 2026 outlook and flags high-end EPS
Solventum (SOLV) is rising after reporting Q1 fiscal 2026 results that beat internal expectations, with adjusted EPS up 10.6% to $1.48 on $2.007B of sales. The company reaffirmed full-year organic sales growth and free-cash-flow guidance and said adjusted EPS is now expected toward the high end of its $6.40–$6.60 range.
1. What’s moving SOLV today
Solventum shares are higher after the company posted first-quarter fiscal 2026 financial results and reiterated its full-year outlook. Investors focused on stronger-than-expected adjusted profitability and management’s commentary that full-year adjusted EPS should land toward the high end of the company’s existing guidance range.
2. The headline numbers
For Q1 (ended March 31, 2026), Solventum reported sales of $2.007 billion, down 3.0% on a reported basis but up 2.1% organically. GAAP diluted EPS was $0.07, while adjusted diluted EPS rose 10.6% year over year to $1.48; operating cash flow was $(189) million and free cash flow was $(273) million.
3. Guidance framing investors are reacting to
Solventum reaffirmed its full-year fiscal 2026 organic sales growth and free cash flow guidance, while indicating adjusted EPS is now expected to come in toward the high end of the previously issued $6.40 to $6.60 range. That combination—no cut to the top-line outlook and a more constructive profit tone—helped offset concerns about the quarter’s cash outflow.
4. What to watch next
Key swing factors for the shares include whether organic growth remains positive across segments, how quickly cost and transformation initiatives translate into sustained margin expansion, and whether cash generation inflects as the year progresses. Investors will also watch commentary from the earnings call for updates on separation-related costs and any incremental actions to improve operating leverage.